Status:
COMPLETED
Preference-Based Exercise RCT for Men With PC on ADT
Lead Sponsor:
University Health Network, Toronto
Collaborating Sponsors:
Canadian Institutes of Health Research (CIHR)
Conditions:
Prostate Cancer
Eligibility:
MALE
Phase:
NA
Brief Summary
Prostate cancer affects 1 in 7 men. Half of these men are treated with androgen deprivation therapy (ADT). ADT slows disease progression and prolongs survival, but it also leads to worse quality of li...
Detailed Description
BACKGROUND: The backbone of scientific evidence to address most scientific questions, including behavioural interventions, is randomized controlled trials (RCTs). Prostate cancer is the most common ma...
Eligibility Criteria
Inclusion
- men with histologically confirmed PC who are starting or continuing on ADT for at least 6 months
- fluent in English,
- able to provide consent.
Exclusion
- already meeting guidelines for moderate to vigorous physical activity (MVPA)
- conditions that would interfere with ability to participate
Key Trial Info
Start Date :
October 19 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 30 2020
Estimated Enrollment :
56 Patients enrolled
Trial Details
Trial ID
NCT03335631
Start Date
October 19 2017
End Date
April 30 2020
Last Update
August 13 2021
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Calgary/Tom Baker Cancer Centre
Calgary, Alberta, Canada
2
Scarborough and Rouge Hospital
Scarborough Village, Ontario, Canada, M1P 2T7
3
University Health Network
Toronto, Ontario, Canada, M5G 2C4